SHANGHAI JUNSHI BIOSCIENCES CO., LTD. * PD

Similar documents
% %

19.38 (i)lvc FundsLoyal Valley Capital Advantage Fund LP Loyal Valley Capital Advantage Fund II LP LVC Renaissance Fund LP (ii) Highbury Investment Pt

ii

880041_C_Unique_REDACTED_.indb

indb

i

INNOVENT BIOLOGICS, INC ,

% % %

I II-1 i

4 663, ,940 (105,073) (65,883) 558, , ,744 30,764 (242,100) (187,191) (58,878) (48,960) (35,254) (26,460) (979) (2,594) ,647

Microsoft Word - 中药_hyc8110_ doc

A 1..56

項 訴 求 在 考 慮 到 整 體 的 財 政 承 擔 以 及 資 源 分 配 的 公 平 性 下, 政 府 採 取 了 較 簡 單 直 接 的 一 次 性 減 稅 和 增 加 免 稅 額 方 式, 以 回 應 中 產 家 庭 的 不 同 訴 求 ( 三 ) 取 消 外 傭 徵 費 6. 行 政 長

(f) (g) (h) (ii) (iii) (a) (b) (c) (d) 208

Microsoft Word - 08 单元一儿童文学理论

untitled

第三章

nb.PDF

bnbqw.PDF

南華大學數位論文

Microsoft Word 一年級散文教案.doc

米食天地教案

第32回独立行政法人評価委員会日本貿易保険部会 資料1-1 平成22年度財務諸表等

1. 本文首段的主要作用是 A. 指出 異蛇 的藥用功效 說明 永之人爭奔走焉 的原因 B. 突出 異蛇 的毒性 為下文 幾死者數矣 作鋪墊 C. 交代以蛇賦稅的背景 引起下文蔣氏有關捕蛇的敘述 2. 本文首段從三方面突出蛇的 異 下列哪一項不屬其中之一 A. 顏色之異 B. 動作之異 C. 毒性之

Microsoft Word - 發布版---規範_全文_.doc

概 述 随 着 中 国 高 等 教 育 数 量 扩 张 目 标 的 逐 步 实 现, 提 高 教 育 质 量 的 重 要 性 日 益 凸 显 发 布 高 校 毕 业 生 就 业 质 量 年 度 报 告, 是 高 等 学 校 建 立 健 全 就 业 状 况 反 馈 机 制 引 导 高 校 优 化 招

鱼类丰产养殖技术(二).doc

疾病诊治实务(一)

名人养生.doc

<4D F736F F D2040B9C5B871A661B0CFABC8AE61C2A7AB55ACE3A8735FA7F5ABD8BFB3B9C5B871A661B0CFABC8AE61C2A7AB55ACE3A8732E646F63>


中老年保健必读(十).doc

27 i

% % ,542 12,336 14,53 16,165 18,934 22,698 25, ,557 7,48 8,877 11, 13,732 17,283 22,

海淀区、房山区(四)

穨ecr1_c.PDF

穨2005_-c.PDF

北京理工大学.doc

尲㐵.⸮⸮⸮⸮⸮

东城区(下)

果树高产栽培技术(一).doc

物质结构_二_.doc

第一節 研究動機與目的

i

水力发电(九)

中国古代文学家(八).doc

景观植物(一)

Microsoft Word - 目录.doc

园林植物卷(三).doc

19q indd

厨房小知识_一_

中南财经大学(七).doc


赵飞燕外传、四美艳史演义

厨房小知识(五)

最新监察执法全书(十八).doc

园林植物卷(十二).doc

华东师范大学.doc

國立中山大學學位論文典藏

乳业竞争_一_

最新执法工作手册(十).doc

untitled

最新执法工作手册(十六)

中国政法大学(六).doc

胎儿健康成长.doc

Microsoft Word - edu-re~1.doc

60 39 [ ]

A H H i

2017/ / , / , GDP 2017/2018 7, / / / % 96.4% 94.1% % 78.4%

,637,097, ,983,285, ,057, ,004, ,908, ,574, ,638, ,715, ,373,

Shandong International Trust Co., Ltd. SITC H

,983,285, ,857,032, ,915, ,586, ,993, ,073, ,638, ,598, ,508,123

%92.1%91.3%93.8%

untitled

地方医药管理与立法(五)

... ii... 1 A A H i

(1) (%) (1%) (1%) (1%) (1%) (1%) (1%) - 2 -

untitled

I 我国中药在国际市场上的竞争优势分析

untitled

最新监察执法全书(一百五十四).doc

i

,083.9 JPG (BVI) JPG (BVI) JPG (BVI) JPG (BVI) JPG (BVI)JPG (BVI) 96.9% 1.4% 1.6% 12.7%

, , (6,476) 1,077, ,765 (5,372) (18,075) (34) 1,053, , ,053, ,255 1,673, ,934 1,706, ,221 (

,095,475, ,945,266, ,817, ,698, ,026, ,103, ,187, ,704,201.6

中国行业季度分析报告

i

马太亨利完整圣经注释—雅歌

二零零六年一月二十三日會議

(1) (2) (3) 1. (1) 2

(Microsoft Word \256\325\260\310\267|\304\263\254\366\277\375.doc)

QINHUANGDAO PORT CO., LTD.* ,876, % 693, % 810, % * 1

1,441, ,052 34,437 30, ,880,622 3,735, , , ,192 34,069 40, , , ,521 4,848,742 5,438, ,283 91,4

(i) (ii) (iii) (iv) 380,000 [ ] , , % % % 5.5% 6.5%

失眠防治(四).doc

厨房小知识(四)

妇女更年期保健.doc

小儿传染病防治(上)

<4D F736F F D B875B9B5A448ADFBBADEB27AA740B77EA4E2A5555FA95EAED6A641ADD75F2E646F63>

女性青春期保健(下).doc

Transcription:

SHANGHAI JUNSHI BIOSCIENCES CO., LTD. * 1877 2018 12 31 2018 12 31 2017 12 31 2018 12 31 0.9 PD-12017 12 31 275.3538.2 2018 2018 12 31 20.3 714.6 2017 12 31 326.9 JS001 2018 12 313,432.6 2,713.2 * 1

421.0 2018 12 (GMP) IIIII NSCLC TNBCII III JS003PD-L1JS101 CDK 2018 810 NMPAIND 2018 12 17JS001PD-1 NMPA JS001 2019 1 7 (JS001) 7,200240mg 2019 2 26 2012 12 2

(first-in-class) (best-in-class) ADC JS001PD-1 JS001 2018 3JS001 PD-1 NDA NMPA2018 12 17 NMPA 128127 FAS 1 CR 21 PR 51 SD ORR 17.3% (22/127) DCR 57.5% (73/127)OS 23.18 69.3% JS001 NDA 3

JS003PD-L1 2018 8JS003 IND NMPA JS003 PD-L1 CDR PD-L1 PD-L1 PD-L1 PD-L1 JS003 PD-L1 PD-1 T JS101 CDK JS101CDKCDK JS101 2018 10 NMPA IND JS101 JS101 JS104 CDK JS105 PI3K- 2019 2 JS104 JS105 JS104 CDK-1 CDK-2 CDK-4 CDK-6 CDK-9 CDK JS105 PI3K PIK3CA PI3K 50% 2019 2 19 UBP1213BLyS UBP1213 BLyS B NMPA IND 4

JS001PD-1 Ib/II JS001EGFR II (EGFR-) III III 2018 1 9JS001 FDA I Ia JS001 III CM082(Vorolanib) 5

JS002PCSK9 JS002PCSK9FDA 2018 12 11 201779.3 2022 95.9 3.9% JS002 JS002 NMPA PCSK9IND 2018 I UBP1211TNF- UBP1211 2017 2017189UBP1211 III 2018 1,500L 3*500L JS001 2018 89 2018 12 GMP2018 10 2018 10 SFE 240 2019 1 7 7,200240mg 2019 2 26 6

1 JS001 PCT 2 JS002PCT 3 JS003PCT 4 UBP1213 2032 2033 PCT 22 6 10 6 7

10 16 69 123 22 20 101 159 32.48% 26.50% 538,182,847.98 275,303,382.16 18,383.24% 505.15% 1 JS001 4.03 7.35 2 UBP1211 0.38 0.91 3 JS005 0.32 0.34 4 JS002 0.23 0.45 5 JS004 0.17 0.21 5.13 9.26 800 8

UBP1211 2019NMPANDA JS001PD-1 Ib/II2019 II JS002PCSK9II JS003PD-L1 2019 3 22FDA(FIH) IgG4TAB004/JS004 IND B T (BTLA) TAB004/JS004 T BTLA TAB004/ JS004 FIH PD-1 JS001 TAB004/JS004 2019 3 25 2019JS005IL-17AIND 1,500L 3*500L2018 1,500L 3*500L2019 9

30,000L 15*2,000L2019 2019 JS001PD-1 2019 ISS RWS 1. 12 31 2018 2017 3,756 2,308 a 4,631 2,614 b 47,420 8,387 52,342 (a) (b) (i) (ii) (iii) 2017 2 28 cgmp 2017 2017 10.8 10

2. 2017 8 28 UBP1211 UBP1211 UBP1211 36.6 UBP1211 2017 12 31 20172018 12 31 275.3 538.2(i) (ii) 3. 2018 12 31 20.3 JS001 4. 20172018 12 3173.8 124.8 (i)(ii) (iii) 5. 2018 12 31 2017 12 31 266.3 2,763.6 11

6. 2018 4 2.0 2018 6 29 2018 12 310.1 7. 12 12 31 2018 2017 (714,593) (326,915) 24,741 6,097 21,700 14,275 (647,780) (326,915)

8. 2018 12 24H 19.38 17.07158,910,000H 3,079.7 2,713.2 2019 1 4 23,836,500 H 462.0 2018 12 11 65% 40% 1,365.1 JS001JS001(i) (ii) III(iii) (iv)i JS001 16% 546.0 (i) UBP1211 I III (ii) JS002 I II III(iii) UBP1213 I II III (iv) 9% 307.1 25% 853.2 10% 341.3 2018 12 31 13

2018 12 24 H 2018 12 31 2019 1 4H 19.3823,836,500 H H158,910,000 182,746,500 2019 1 4 (JS001) Vorolanib(CM082) 2018 7 18NMPA2019 1 NMPA 2019 1 18 2019 2 (JS001) (CM4307) 2019 2 14 2019 2 19 CDKPI3K 50%150 2019 2 19 14

2018 12 31 2019 5 15 (www.junshipharma.com)(www. hkexnews.hk) 2019 5 15 HH2019 4 15 2019 5 15H H 2019 4 12 HH 183 22 15

2018 12 31 12 31 2018 2017 4 934 1,148 (267) (446) 667 702 8,387 52,342 (32,641) (24,599) (638) (165) (538,183) (275,303) (20,304) (124,837) (73,752) (4) 31 (6,097) (4,063) 5 (717,713) (320,744) 1,213 (58) (716,500) (320,802) 147 (269) (716,353) (321,071) (9,367) 10,638 (5,480) 227 (364) 262 1,760 (5,844) (714,593) (326,915) 16

12 31 2018 2017 (716,503) (320,683) 89 (161) (716,414) (320,844) 3 (119) 58 (108) 61 (227) (716,353) (321,071) (714,654) (326,688) 61 (227) (714,593) (326,915) 3 (1.19) (0.55) (1.19) (1.19) (0.55) (1.19) 17

2018 12 31 12 31 2018 2017 939,341 359,626 74,408 69,553 1,519 1,455 266 1,027 1,031 1,288 139 311,607 272,246 7 18,000 4,323 1,347,126 708,703 48,468 30,603 8 220 92,630 39,490 7 5,516 147,434 26,961 2,763,570 266,298 2,910,184 511,006 9 291,322 41,499 1,111 646 10 178,632 381 7 16,034 471,065 58,560 2,439,119 452,446 3,786,245 1,161,149 18

12 31 2018 2017 10 150,000 28,302 11 241,763 45,047 41,815 465,112 41,815 3,321,133 1,119,334 12 760,310 584,750 2,561,936 535,758 3,322,246 1,120,508 (1,113) (1,174) 3,321,133 1,119,334 19

1. 2012 12 27 2015 52015 8 833330 2018 12 24H 781 602 183 54 2. 20182017 12 31 2018 1 1 20182017 12 31 2019 1 1 9 16 1 17 3 23 1 3 4 10 28 2 1 5 8 19 1 28 1 2015 2017 1 1 2019 1 1 2 3 2021 1 1 4 2020 1 1 5 2020 1 1 20

3. (a) 12 31 2018 2017 (716,414) (320,844) 12 31 2018 2017 601,917,890 579,608,904 12 31 2018 2017 (716,414) (320,844) 89 (161) (716,503) (320,683) 2018 12 31 0.01 2017 0.032018 12 31 89,000 2017 161,000 21

(b) 11 2018 5 14 2018 12 31 2017 12 31 2017 12 31 4. 20172018 12 31 20172018 12 31 2017 2018 12 31 1.1 0.9 5. 20172018 25% 2017 12 3115% 35% 2017 12 222018 1 1 21% 2018 12 31TopAlliance Biosciences Inc. 8.84% 20178.84%TopAlliance Biosciences Inc. 12 31 2018 2017 418 (64) (64) 418 (1,149) (360) (1,213) 58 6. 20182017 12 31 22

7. 12 31 2018 2017 a 5,500 45,000 b 16 102,434 5,516 147,434 c 18,000 d 4,323 e 16,034 (a) (b) (c) (d) (e) 721 2018 12 31 3.95% 20172.74% 3.13% 2018 12 31 2018 4 15,000,000 5% 2018 9 3,000,000 15% 2013 8 2018 3 2017 12 31 15,000,000 2018 5 15 1 7.0092 2,000,000 2018 5 15 1 7.0092 18,000,000 2018 5 16 1 7.0213 2018 12 31 23

8. 2018 12 312018 1 1 220,000 12 31 2018 2017 0 30 31 90 91 180 1811 1 2 106 31 33 24 26 220 9. 12 31 2018 2017 3,620 3,685 36,558 12,621 80,025 777 81,049 4,195 7,867 13,394 50,901 16,160 2,126 323 14,415 32 1,367 3,706 291,322 41,499 24

12 31 2018 2017 0 30 33,372 15,289 31 60 198 207 61 180 81 209 180 6,527 601 40,178 16,306 10. 12 31 2018 2017 150,225 18,132 168,357 160,275 328,632 178,632 150,000 328,632 (178,632) 150,000 25

11. 2018 2 9 500,000,000 2018 2 23 200,000,000 2018 2 23 200,000 32,396 9,367 12. 2018 12 31 241,763 1.0 2017 1 31 550,000,000 550,000 2017 2 24 a 34,750,000 34,750 2017 12 31 584,750,000 584,750 2018 3 7 b 16,650,000 16,650 Hc 158,910,000 158,910 2018 12 31 760,310,000 760,310 26

(a) (b) (c) 2017 2 24 34,750,000 66,000319,634,000 34,750,000 284,884,000 2018 3 7 16,650,000 1,745,000297,955,000 16,650,000 281,305,000 2018 12 2419.38 17.07158,910,000H 3,079,676,000 2,713,194,000 158,910,000 2,554,284,000 H 27

2018 12 31 1 2 NMPA FDA 28

3 GMP 4 2018 12 17 NMPA 5 4+7 29

6 1 NMPA FDA 30

2 GMP 3 31

2018 32 2,763,570,176.83 293,259,373.25 16,402.95 106,756,911.89 6,635,819.82 973,582.93 44,654,789.45 28,721,316.77 6,242,443.73 9,061,729.76 48,467,546.06 30,601,576.03 953,265.70 40,596,756.49 45,000,000.00 2,910,183,935.33 515,327,756.33 1,027,261.40 1,030,943.07 18,000,000.00 259,654,365.00 235,962,271.14 669,870,253.79 123,071,176.90 75,863,697.85 69,818,553.34 1,518,979.51 2,825,984.02 807,048.66 1,287,876.31 139,412.34 311,607,478.72 272,031,944.58 1,340,136,917.09 704,380,329.54 4,250,320,852.42 1,219,708,085.87

18,132,121.03 16,034,072.32 217,395,035.17 21,277,732.58 1,111,152.00 646,207.57 50,901,300.80 16,160,104.14 2,126,240.45 704,208.95 181,401,160.76 3,737,370.00 471,067,010.21 58,559,695.56 150,000,000.00 241,763,000.00 45,046,569.33 41,814,860.37 28,301,886.78 465,111,456.11 41,814,860.37 936,178,466.32 100,374,555.93 33

760,310,000.00 584,750,000.00 3,797,238,509.95 1,056,407,351.21-9,517.84-1,281,398.32-1,242,283,592.26-519,368,145.10 3,315,255,399.85 1,120,507,807.79-1,113,013.75-1,174,277.85 3,314,142,386.10 1,119,333,529.94 4,250,320,852.42 1,219,708,085.87 34

2,630,582,406.18 117,656,921.86 106,717,231.89 11,135,318.83 9,847,170.88 8,303,061.04 4,224,336.20 15,847,383.90 464,927.82 22,085,161.44 2,687,953,331.39 238,910,588.65 1,237,911,814.18 534,221,935.65 18,000,000.00 20,648,776.63 19,814,879.21 334,378.66 863,370.59 164,794,827.94 502,415,421.65 1,442,553,168.00 1,056,452,236.51 4,130,506,499.39 1,295,362,825.16 35

18,132,121.03 16,034,072.32 88,879,389.72 7,333,564.78 22,526,781.25 3,716,285.81 1,610,350.80 83,652.99 181,018,426.24 1,485,905.30 312,167,069.04 28,653,481.20 241,763,000.00 12,374,586.75 8,348,575.21 28,301,886.78 282,439,473.53 8,348,575.21 594,606,542.57 37,002,056.41 760,310,000.00 584,750,000.00 3,784,419,306.04 1,043,588,147.30-9,367,000.00-999,462,349.22-369,977,378.55 3,535,899,956.82 1,258,360,768.75 4,130,506,499.39 1,295,362,825.16 36

2,927,573.86 54,499,848.63 2,927,573.86 54,499,848.63 710,292,306.98 353,558,654.57 1,952,996.83 5,158,451.79 2,243,708.99 967,983.42 20,493,967.88 543,502.53 132,028,850.53 73,658,668.46 538,182,847.98 275,303,382.16 14,738,554.33-2,224,360.30 3,755,992.59 2,308,189.27 151,026.51 651,380.44 4,599,930.24 2,599,109.69 - -26,803,083.15 5,888,332.86-3,681.67 31,324.24 - - 10,270,189.60-26,955,985.55-102.84 - - -719,297,593.59-317,527,348.94 32,160.49 14,793.13 4,802,041.57 50.00 - -724,067,474.67-317,512,605.81-1,213,291.61 58,189.75 37

- -722,854,183.06-317,570,795.56 1. - -723,293,622.07-317,570,795.56 2. - 439,439.01 1. 61,264.10-227,257.16 2. -722,915,447.16-317,343,538.40 1,271,880.48-9,344,269.04 1,271,880.48-9,344,269.04 1. 2. 3. 4. 1,271,880.48-9,344,269.04 1. 2. -9,367,000.00 3. -3,864,034.71 4. 5. 6. 7. 10,638,880.48-5,480,234.33 8. -721,582,302.58-326,915,064.60-721,643,566.68-326,687,807.44 61,264.10-227,257.16-1.21-0.55-1.21-0.55 38

89,622.64 12,594,718.70 60,000.00 1,121,745.90 389,133.40 20,303,927.76 57,508,921.17 14,090,250.97 272,185,443.35 164,039,202.91 16,317,242.34-1,767,849.78 2,090,574.40 1,802,761.10 241,339,980.30 149,194,023.44 523,560.83 1,107,250.49 1,548,904.79 - -27,446,878.85 10,424,233.50-3,681.67 31,324.24 - - 10,269,586.65-25,380,965.41 - - - -625,341,240.72-326,757,869.36 32,160.00 5,673.13 4,175,889.95 - -629,484,970.67-326,752,196.23 - -629,484,970.67-326,752,196.23-629,484,970.67-326,752,196.23 39

-9,367,000.00-3,864,034.71 1. 2. 3. 4. -9,367,000.00-3,864,034.71 1. 2. -9,367,000.00 3. -3,864,034.71 4. 5. 6. 7. 8. -638,851,970.67-330,616,230.94 40

28,861,135.72 59,445,538.46 49,123,938.44 7,863,799.69 14,958,171.50 85,848,873.85 74,403,709.96-8,266,286.57 58,708,234.24 102,980,389.09 52,989,008.87 952,967.92 1,104,330.22 507,133,083.01 272,902,143.07 602,800,153.45 385,703,716.40-516,951,279.60-311,300,006.44 41

539,007,841.24 1,604,830,000.00-24,895,715.13 5,857,008.62 775.86 1,253,767.70 30,717,670.40 51,174,773.83 546,084,340.07 1,661,861,782.45 557,372,243.51 333,926,196.87 403,500,000.00 1,176,000,000.00 960,872,243.51 1,509,926,196.87-414,787,903.44 151,935,585.58 3,212,894,379.80 319,700,000.00 434,132,121.03 3,647,026,500.83 319,700,000.00 106,000,000.00 2,656,145.77 105,768,083.88 66,037.73 214,424,229.65 66,037.73 3,432,602,271.18 319,633,962.27-3,590,606.75-5,358,923.94 2,497,272,481.39 154,910,617.47 266,297,695.44 111,387,077.97 2,763,570,176.83 266,297,695.44 42

30,095,738.21 14,788,979.75 11,351,288.48 5,510,984.15 9,903,153.13 46,958,010.84 24,692,132.88-46,424,953.19 4,817,223.26 37,419,091.04 13,274,057.46-404,951.91 373,061.04 707,472,232.95 347,842,544.55 698,061,418.89 366,306,886.31-651,103,408.05-341,614,753.43 463,981,822.36 1,604,830,000.00-25,097,932.94 10,392,909.26 29,052,252.21 2,201,083.29 467,936,141.63 1,617,423,992.55 47,192,426.03 9,007,487.29 498,929,200.00 1,508,546,000.00 546,121,626.03 1,517,553,487.29-78,185,484.40 99,870,505.26 43

3,212,894,379.80 319,700,000.00 284,132,121.03 3,497,026,500.83 319,700,000.00 106,000,000.00 1,807,277.11 105,768,083.88 66,037.73 213,575,360.99 66,037.73 3,283,451,139.84 319,633,962.27-14,275,085.26 2,539,887,162.13 77,889,714.10 90,695,244.05 12,805,529.95 2,630,582,406.18 90,695,244.05 44

584,750,000.00 1,056,407,351.21-1,281,398.32-519,368,145.10-1,174,277.85 1,119,333,529.94 584,750,000.00 1,056,407,351.21-1,281,398.32-519,368,145.10-1,174,277.85 1,119,333,529.94-175,560,000.00 2,740,831,158.74 1,271,880.48-722,915,447.16 61,264,10 2,194,808,856.16 1,271,880.48-722,915,447.16 61,264,10-721,582,302.58 175,560,000.00 2,740,831,158.74 2,916,391,158.74 1. 175,560,000.00 2,719,131,222.12 2,894,691,222.12 2. 3. 4. 21,699,936.62 21,699,936.62 1. 2. 3. 4. 1. 2. 3. 4. 5. 6. 1. 2. 760,310,000.00 3,797,238,509.95-9,517.84-1,242,283,592.26-1,113,013.75 3,314,142,386.10 45

550,000,000.00 771,523,388.94 8,062,870.72-202,024,606.70-947,020.69 1,126,614,632.27 550,000,000.00 771,523,388.94 8,062,870.72-202,024,606.70-947,020.69 1,126,614,632.27-34,750,000.00 284,883,962.27-9,344,269.04-317,343,538.40-227,257.16-7,281,102.33-9,344,269.04-317,343,538.40-227,257.16-326,915,064.60 34,750,000.00 284,883,962.27 319,633,962.27 1. 34,750,000.00 284,883,962.27 319,633,962.27 2. 3. 4. 1. 2. 3. 4. 1. 2. 3. 4. 5. 6. 1. 2. 584,750,000.00 1,056,407,351.21-1,281,398.32-519,368,145.10-1,174,277.85 1,119,333,529.94 46

584,750,000.00 1,043,588,147.30-369,977,378.55 1,258,360,768.75 584,750,000.00 1,043,588,147.30-369,977,378.55 1,258,360,768.75-175,560,000.00 2,740,831,158.74-9,367,000.00-629,484,970.67 2,277,539,188.07-9,367,000.00-629,484,970.67-638,851,970.67 175,560,000.00 2,740,831,158.74 2,916,391,158.74 1. 175,560,000.00 2,719,131,222.12 2,894,691,222.12 2. 3. 21,699,936.62 21,699,936.62 4. 1. 2. 3. 4. 1. 2. 3. 4. 5. 6. 1. 2. 760,310,000.00 3,784,419,306.04-9,367,000.00-999,462,349.22 3,535,899,956.82 47

550,000,000.00 758,704,185.03 3,864,034.71-43,225,182.32 1,126,614,632.27 550,000,000.00 758,704,185.03 3,864,034.71-43,225,182.32 1,126,614,632.27-34,750,000.00 284,883,962.27-3,864,034.71-326,752,196.23-10,982,268.67-3,864,034.71-326,752,196.23-330,616,230.94 34,750,000.00 284,883,962.27 319,633,962.27 1. 34,750,000.00 284,883,962.27 319,633,962.27 2. 3. 4. 1. 2. 3. 4. 1. 2. 3. 4. 5. 6. 1. 2. 584,750,000.00 1,043,588,147.30-369,977,378.55 1,258,360,768.75 48

2018 (www.junshipharma.com) (www.hkexnews.hk) (www.neeq.com.cn) 2018 2019 3 29 Roy Steven Herbst * 49